Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reinheckel

Theranostics

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Theranostics|August 22, 2017
New Kid on the BlockThomas Reinheckel
Theranostics|June 8, 2022
RNA interference screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cellsLena Hölzen, Jan Mitschke, Claudia Schönichen, et al.
Theranostics|May 17, 2021
A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironmentLindsay B Alcaraz, Aude Mallavialle, Timothée David, et al.
Theranostics|July 9, 2019
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactionsJohannes Schwenck, Andreas Maurer, Birgit Fehrenbacher, et al.
Theranostics|April 11, 2025
<i>In vivo</i> molecular imaging of breast cancer metabolic heterogeneity using [1-<sup>13</sup>C]pyruvate-d<sub>3</sub> hyperpolarized by reversible exchange with parahydrogenStefan Petersen, Luca Nagel, Philipp R Groß, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Theranostics|August 22, 2017
New Kid on the BlockThomas Reinheckel
Theranostics|June 8, 2022
RNA interference screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cellsLena Hölzen, Jan Mitschke, Claudia Schönichen, et al.
Theranostics|May 17, 2021
A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironmentLindsay B Alcaraz, Aude Mallavialle, Timothée David, et al.
Theranostics|July 9, 2019
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactionsJohannes Schwenck, Andreas Maurer, Birgit Fehrenbacher, et al.
Theranostics|April 11, 2025
<i>In vivo</i> molecular imaging of breast cancer metabolic heterogeneity using [1-<sup>13</sup>C]pyruvate-d<sub>3</sub> hyperpolarized by reversible exchange with parahydrogenStefan Petersen, Luca Nagel, Philipp R Groß, et al.
Pageof 1